183 related articles for article (PubMed ID: 35898891)
1. The Role of SETBP1 in Gastric Cancer: Friend or Foe.
Fang F; Liu C; Li Q; Xu R; Zhang T; Shen X
Front Oncol; 2022; 12():908943. PubMed ID: 35898891
[TBL] [Abstract][Full Text] [Related]
2. LUM Expression and Its Prognostic Significance in Gastric Cancer.
Chen X; Li X; Hu X; Jiang F; Shen Y; Xu R; Wu L; Wei P; Shen X
Front Oncol; 2020; 10():605. PubMed ID: 32500021
[No Abstract] [Full Text] [Related]
3. Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients.
Li X; Chen X; Hu X; Shen Y; Xu R; Wu L; Shen X
Front Oncol; 2021; 11():632172. PubMed ID: 34113559
[TBL] [Abstract][Full Text] [Related]
4. TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Fang F; Zhang T; Lei H; Shen X
PeerJ; 2023; 11():e15613. PubMed ID: 37404478
[TBL] [Abstract][Full Text] [Related]
5. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
[TBL] [Abstract][Full Text] [Related]
6. High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients.
Wang Y; Zhang S; Wang H; Cui Y; Wang Z; Cheng X; Li W; Hou J; Ji Y; Liu T
Front Oncol; 2020; 10():966. PubMed ID: 32766126
[No Abstract] [Full Text] [Related]
7. Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer.
Zeng J; Li M; Shi H; Guo J
Front Med (Lausanne); 2021; 8():672595. PubMed ID: 34291059
[No Abstract] [Full Text] [Related]
8. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
Huang C; Zhao J; Luo C; Zhu Z
Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
[No Abstract] [Full Text] [Related]
9. A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients.
Chen D; Wang M; Xu Y; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
Int J Gen Med; 2021; 14():6935-6950. PubMed ID: 34703297
[TBL] [Abstract][Full Text] [Related]
10. Trim47 overexpression correlates with poor prognosis in gastric cancer.
Xia Y; Wei Z; Huang W; Wei X; He Y
Neoplasma; 2021 Mar; 68(2):307-316. PubMed ID: 33350849
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlations and prognostic value of Nudix hydroxylase 10 in patients with gastric cancer.
Chen D; Zhang R; Xie A; Yuan J; Zhang J; Huang Y; Zhang H; Zhang F
Bioengineered; 2021 Dec; 12(2):9779-9789. PubMed ID: 34696672
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Chen S; Duan H; Xie Y; Li X; Zhao Y
Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
[TBL] [Abstract][Full Text] [Related]
13. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
Front Oncol; 2020; 10():603480. PubMed ID: 33425760
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
15. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
[No Abstract] [Full Text] [Related]
16. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer.
Zhao Z; Li S; Li S; Wang J; Lin H; Fu W
Cancer Cell Int; 2021 Sep; 21(1):493. PubMed ID: 34530820
[TBL] [Abstract][Full Text] [Related]
17. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
Front Genet; 2022; 13():803460. PubMed ID: 35186032
[No Abstract] [Full Text] [Related]
18. Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer.
Zhong Y; Zhuang Z; Mo P; Shang Q; Lin M; Gong J; Huang J; Mo H; Huang M
Evid Based Complement Alternat Med; 2021; 2021():5557873. PubMed ID: 34567213
[TBL] [Abstract][Full Text] [Related]
19. Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
Meng X; Wang L; He M; Yang Z; Jiao Y; Hu Y; Wang K
PLoS One; 2022; 17(6):e0269998. PubMed ID: 35771747
[TBL] [Abstract][Full Text] [Related]
20. High
Yuan L; Hu C; Yu P; Bao Z; Xia Y; Zhang B; Wang Y
Ann Transl Med; 2022 Sep; 10(18):990. PubMed ID: 36267769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]